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Abstract - Schizophrenia is a chronic disorder that ultimately leads to a decline in cognitive, social and emo-
tional functioning. Although the aetiology of the disorder is still unknown, it is most likely multifactorial, with 
equal importance of environmental and genetic factors. It has been hypothesized that those same factors 
influence aggressive symptomatology and possibly even violence in schizophrenia. The association between 
schizophrenia and aggressive behaviour is well documented; however, the impact of genetic alterations and 
gene polymorphisms on the incidence and type of violence in this group of patients has rarely been the focus 
of scientific research. Both violence and aggression are complex behavioural patterns that lead to difficulties 
in the comparability of genetic studies and limits their clinical applicability. In this review paper we systemati-
cally presented findings from studies examining the association between gene polymorphisms of the dopa-
mine and serotonin systems and aggressive symptoms and violent behaviour in schizophrenia.
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Introduction
Schizophrenia is a chronic disorder with 
recurrent course and a variety of  different 
clinical presentations. It is characterized by 
acute episodes followed by periods of  par-
tial or complete remissions, with every ex-
acerbation leading to a decline in cognitive 
and emotional functioning in the long run 
[1]. Since there is no biological marker or a 
laboratory test which would help diagnose 
schizophrenia it is currently diagnosed by us-
ing a set of  defined descriptive criteria. The 
most commonly used criteria are the 10th 
revision of  the International Classification 
of  Diseases (ICD-10) by the World Health 
Organization [2] and the fifth edition of  the 
Diagnostic and Statistical Manual of  Mental 
Disorders (DSM-5) of  the American Psychi-
atric Association [3]. 
For years classical psychiatric practice has 
used the dichotomous division of  schizo-
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phrenia symptoms into positive and negative, 
which usually resulted in neglecting other 
symptom domains or combining them with 
the positive and negative symptoms. Multi-
dimensional concept of  schizophrenia allows 
grouping of  symptoms into five clusters: 
positive, negative, cognitive, affective or de-
pressive and aggressive [1,4]. Since aggressive 
or hostile symptoms can be found in other 
psychiatric disorders (bipolar affective disor-
der, personality disorders, dementia, atten-
tion deficit hyperactivity disorder, etc.) and 
some somatic disorders, they are not specific 
to schizophrenia. These symptoms include 
hostility, self-harm, property damage, arson 
and sexual impulsivity [1,5]. One of  the ma-
jor public health problems is violence and es-
pecially when caused by psychiatric patients 
[6]. Although most psychiatric patients are 
not violent, an epidemiological study in 1990 
found significant association between schizo-
phrenia and an increased risk of  violent be-
haviour [7]. Current American Psychiatric 
Association practice guidelines for the treat-
ment of  patients with schizophrenia suggest 
that identifying risk factors for violence and 
assessment of  dangerousness are parts of  a 
standard psychiatric evaluation, which should 
be conducted in a safe environment [8].
Swedish study, which included 24,297 pa-
tients diagnosed with schizophrenia from 
1972 to 2009, has shown that 10.7 % of  men 
and 2.7 % of  women had been convicted of  
a violent offense within the first five years of  
diagnosis. These patients had an increased 
risk of  death with 3.3 % of  men and 2% of  
women dying prematurely of  any cause. The 
odds ratio for the negative outcome was 7.5 
in men and 11.1 in women compared to the 
general population. During the follow-up, 
the ratio increased over time compared to the 
siblings of  the patients in the follow up [9]. 
Most patients with schizophrenia (72%) who 
commit a crime do so before the first contact 
with a psychiatrist. A meta-analysis published 
in 2011 has shown that 35% of  patients with 
a first psychotic episode had previously com-
mitted at least one offence [10]. Meta-analysis 
by Nielssen and Large also demonstrated by 
that patients who had a first psychotic epi-
sode (before treatment) had 15.5 times high-
er risk of  homicide than the general popula-
tion [11].
There is a number of  factors associated 
with an increased risk of  violence which are 
well known, some of  which are related to 
psychotic symptoms such as hallucinations 
or delusions, while others are related to co-
morbidities or demographic factors. The 
most important risk factors associated with 
psychosis are untreated psychotic symptoms, 
especially persecutory delusions and the Cap-
gras syndrome. Comorbidities include sub-
stance abuse, antisocial personality disorders 
and mood disorders, although anxiety and 
negative symptoms have been shown to re-
duce the risk of  violence. Other risk factors 
include hostility, poor social skills, a history 
of  violence or history of  physical or sexual 
abuse. Although low levels of  intelligence are 
associated with the violence of  psychotic pa-
tients, the level of  intelligence by itself  is not 
a predictor since, for example, many violent 
paranoid patients are above average intelli-
gent [12]. Key demographic factors include 
male gender, younger age, low socioeconom-
ic status, life in a poorer setting, and being a 
child of  a father with a history of  substance 
abuse or abandonment by father before the 
age of  15. Systematic review of  the risk of  
violence in schizophrenia and other psycho-
ses performed by Fazel and associates in 2009 
found that comorbidity with substance use 
disorders substantially increased the risk of  
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violence. However, this study also suggests 
that individuals with substance use disorders 
may be more dangerous than patients with 
schizophrenia (or other psychoses) without 
comorbid substance abuse. In other words, 
psychoses comorbid with substance abuse 
confer no additional risk over the risk associ-
ated with the substance abuse alone [13].
Modern brain imaging techniques can iden-
tify the structural and functional abnormali-
ties associated with violence in patients with 
schizophrenia, but in most cases these findings 
are still common to all violent offenders [12]. 
In patients with schizophrenia with a history 
of  violence or high aggression scores the most 
common findings were reduced volumes of  
the hippocampus and the frontal lobe which 
suggests that dysfunction of  fronto-limbic re-
gions in schizophrenia may be associated with 
aggression or violence [14].
Although many reports address the link 
between violence and schizophrenia, only a 
small number of  studies have addressed the 
possible link between genetic changes or gene 
polymorphisms and aggression in schizo-
phrenia. In this review, we aimed to focus on 
the association between commonly studied 
gene polymorphisms and aggressive symp-
toms of  schizophrenia. We have examined 
studies published and available on PubMed 
and Scopus, while summarizing the results of  
different original studies and meta-analyses. 
Our search of  MeSH terms: schizophrenia, 
aggression/violence and gene/polymor-
phisms yielded a total of  46, however due to 
repetition a total of  34 studies were finally 
included in this review.
Findings from genetic studies
The incidence of  schizophrenia is known 
to be significantly higher in certain fami-
lies than in the general population, suggest-
ing that there is some form of  inheritance. 
Unlike in monogenetic diseases, in which a 
certain genotype leads to a disease in almost 
all cases, in schizophrenia the correlation 
between genotype and phenotype is signifi-
cantly weaker. It is generally accepted that 
heritability (a genetic contribution to the ob-
served phenotypic variance) in schizophrenia 
ranges between 64 and 81%. Children of  par-
ents with schizophrenia are ten times more 
likely to develop the disease than the general 
population. Risk of  the disease in a family of  
a schizophrenic patient declines significant-
ly faster than the proportion of  genes they 
share, suggesting that classic (Mendelian) 
model of  inheritance may not apply here. 
Despite its high heritability, most cases of  the 
disease are still sporadic. The low prevalence 
of  the disease (which is about 1 % in schizo-
phrenia) combined with high heritability and 
occurrence of  more sporadic than familial 
cases of  the disease primarily corresponds to 
the polygenic inheritance model [15,16].
Twin studies conducted on patients with 
schizophrenia and their siblings have shown 
that genotype contributes to less than 50% 
of  the etiology of  the disease. Therefore, 
many environmental factors are being tested 
as a trigger for the development of  the dis-
ease in a predisposed individual. Epidemio-
logical studies indicate a number of  factors 
associated with an increased risk of  devel-
oping schizophrenia such as prenatal infec-
tion and activation of  the immune system, 
father’s age, malnutrition, obstetric complica-
tions leading to hypoxia, social stress in child-
hood and adolescence, and cannabis abuse. 
The multihit model suggests a person is par-
ticularly sensitive to exposure to adverse en-
vironmental events, which could eventually 
trigger biological consequences associated 
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with schizophrenia, in two time periods of  
life, specifically, during early development of  
brain and during its maturation during ado-
lescence [17].
Numerous genetic studies have examined 
the gene candidates possibly responsible for 
the development of  schizophrenia. Some of  
the genes tested are neuregulin 1 (localized 
on chromosome 8p), dysbindin (chromo-
some 6p), activator of  D-amino acid oxidase 
(chromosome 13), disrupted in schizophre-
nia 1 (DISC1) (chromosome 1), neurogranin, 
genes of  the major histocompatibility com-
plex and several others. The genes regulating 
the serotonergic and catecholaminergic sys-
tems are key candidates for genetic basis of  
human aggression [14]. The most commonly 
studied genes and their polymorphisms as-
sociated with violence in schizophrenia are 
the genes for catechol-o-methyltransferase 
(COMT), serotonin transporter (SERT), 
monoamino oxidase A (MAO-A), and brain-
derived neurotrophic factor (BDNF) [18].
Catechol-o-methyltransferase (COMT)
COMT is a tissue-nonspecific enzyme re-
sponsible for the degradation of  dopamine. 
It was first described in 1958 by Axelrod and 
associates. COMT catalyses the transfer of  
the coenzyme methyl group S-adenosyl-L-
methionine (AdoMet) to one of  the hydrox-
yls of  the catecholamine in the presence of  
magnesium. By catalysing this methylation, 
COMT leads to the inactivation of  catechol-
amine neurotransmitters such as dopamine, 
noradrenaline and adrenaline and catechol 
drugs such as levodopa [19].
The COMT gene is located on chromo-
some 22q11.2 and has been considered as a 
potential susceptibility gene for schizophre-
nia. It is also considered relevant in the search 
for a neurobiological basis for aggression in 
schizophrenia patients. There are significant 
variations in enzymatic activity due to com-
mon genetic polymorphisms of  the COMT 
gene. Functional polymorphism (valine [Val] 
or methionine [Met]) at codon 108 deter-
mines enzymatic activity (Val158Met poly-
morphism). The Met allele is less stable and 
has 3 to 4 times lower biological activity than 
the Val allele. Persons with two copies of  the 
Met allele or a deletion are thought to have 
correspondingly higher levels of  dopamine 
in certain regions of  the brain, especially in 
the prefrontal cortex.
In 1997, Strous and associates evaluat-
ed 37 patients with schizophrenia based on 
a history of  violent and threatening behav-
iour, crimes committed, cocaine and alcohol 
abuse as well as other antisocial behaviour. 
The aforementioned group of  authors found 
an association between low COMT activity 
polymorphisms and a higher risk for aggres-
sive and dangerous behaviour compared to 
patients who were homozygous for high ac-
tivity [20]. Furthermore, Gogos and associ-
ates demonstrated a significant influence of  
COMT in some aspects of  emotional and so-
cial behaviour on the knockout mouse mod-
el. Male mice which were heterozygotes for 
COMT deficiency have shown significantly 
increased aggression [21].
Over the following years, several stud-
ies have also demonstrated the association 
of  the Met allele with an increased risk of  
violence in schizophrenia patients [22-28]. 
Contrary to previous findings, in 2001 Jones 
and associates demonstrated a significant dif-
ference between homozygotes for the high 
activity genotype of  COMT and heterozy-
gotes, while there was no difference between 
homozygotes for high and low activity. The 
authors state that their result is a possible ex-
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ample of  heterosis, where heterozygosity is a 
protective factor against a violent behaviour. 
It also needs to be emphasized that several 
studies have not demonstrated an association 
of  COMT gene polymorphism with violent 
behaviour in schizophrenia [29-32]. In 2012, 
Bhakta and associates performed a meta-
analysis which covered all previous studies 
on the association between COMT Met158 
alleles and violence in schizophrenia [33]. 
The results of  the meta-analysis suggest that 
men with the Met allele, that is, low COMT 
activity, are at increased risk of  violent be-
haviour. As patients included in the studies 
of  the meta-analysis were mostly men (80%), 
the power to detect relationship of  COMT 
activity and violence in women was limited. 
Same year, Singh and colleagues published 
another meta-analysis which has shown that 
men with least one Met allele have approxi-
mately 50% higher risk of  violent behaviour 
compared to individuals homozygous for 
the Val allele. No significant association was 
found between the presence of  the Met allele 
and violence in women or when the outcome 
was limited to homicides. On a group of  591 
subjects, 300 of  whom were patients with 
schizophrenia and the other 291 healthy vol-
unteers of  the control group, our group of  
authors did not demonstrate an association 
between COMT polymorphisms and aggres-
sive symptoms in schizophrenia as measured 
by the PANSS scale [34].
Monoamino oxidase (MAO)
MAO is a mitochondrial-bound enzyme 
that catalyses the oxidative deamination of  
dietary amines, monoamine neurotransmit-
ters and hormones. This broad spectrum of  
substrates includes several significant biogen-
ic molecules: indolamines such as serotonin 
(5-hydroxytryptamine, 5-HT) and tryptamine; 
catecholamines, such as dopamine, noradren-
aline and adrenaline; and trace amines, such 
as beta phenylethylamine (PEA), tyramine 
and octopamine. Rapid degradation of  brain 
monoamines is crucial for the proper func-
tion of  synaptic neurotransmission. Mono-
aminergic signalling is considered to be one 
of  the key mechanisms in modulation of  
mood and emotions, as well as for control 
of  motor, perceptual and cognitive func-
tions. There are two different types of  MAO, 
named A and B, which have shown differ-
ence in sensitivity to their substrates and in-
hibitors. MAO-A shows a greater affinity for 
serotonin and noradrenaline, while MAO-B 
prefers PEA and other trace amines. Both en-
zymes contribute similarly to the metabolism 
of  dopamine and other monoamines. The 
genes for both enzymes are located on the 
short arm of  chromosome X (Xp11.23) [35]. 
Among the genes tested for predisposition 
to violence, the key role of  the MAOA gene 
encoding the MAO-A enzyme is increasing-
ly emphasized. The role of  MAO-A in the 
neurobiological basis of  violence has also 
been confirmed by preclinical studies. Stud-
ies on MAOA knockout mice have shown 
that the deficiency of  this enzyme leads to 
marked aggression, maladaptive defensive re-
activity, impaired information processing and 
repetitive responses [36]. The loss of  func-
tion mutation of  the MAOA gene results 
in Brunner’s syndrome characterized by an 
exaggerated tendency to violent behaviour 
in response to minor stressors [37]. A func-
tional polymorphism located in the promoter 
region of  the MAOA gene (uVNTR) is char-
acterized by a tandem repeat variable number 
(VNTR) of  30 base pairs expressing five al-
leles of  2, 3, 3.5, 4, and 5 copies [38]. These 
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polymorphisms have been studied in patients 
with schizophrenia and aggressive behaviour.
A study performed by Zammit and associ-
ates in 2004 failed to demonstrate an associa-
tion between MAO-A gene polymorphisms 
and aggressive behaviour as measured by the 
overt aggression scale in a group of  346 pa-
tients with schizophrenia [31]. Another study 
conducted in 2007 by Fresan and associates, 
on a sample of  71 patients, also did not dem-
onstrate an association between MAO-A 
genes and aggressive behaviour in schizo-
phrenic patients. However, in this study, by 
analysing aggression against the OAS scale, 
a significant association between the 4R al-
lele and verbal aggression was demonstrated 
[39]. An association study and meta-analysis 
of  373 psychiatric patients, 164 of  whom 
were diagnosed with schizophrenia, did not 
demonstrate an association between MAO-
A-uVNTR and suicidal behaviour in neither 
the whole group nor in a group of  patients 
with schizophrenia [40]. Contrary to these 
findings, in a sample of  300 patients with 
schizophrenia our group of  authors has pre-
viously established an association between 
this MAOA polymorphism and aggressive/
impulsive symptoms (as well as negative 
symptoms) [41].
Serotonin transporter (SERT)
SERT has a crucial role in modulating 
the amount of  serotonin (5-HT) in the syn-
apse by controlling intake to the presynaptic 
terminals. The gene encoding human SERT 
is located on chromosome 17q12 and has a 
polymorphism in the 5’ promoter region of  
the gene (5HTTLPR), more specifically, in-
sertion or deletion of  44 bp leading to a long 
allele ‘’LA’’ with high transcriptional activity 
or “LG” and short “S” allele which both have 
lower transcriptional activity. Rates of  SERT 
are decreased in the brain or platelets of  sui-
cidal patients and suicide attempters, in the 
brain of  patients with impulsive violent be-
haviour, and the level of  SERT in platelets 
is inversely related to aggression in patients 
with personality disorders [42,43].
In a French study of  185 patients with 
schizophrenia there was a higher incidence 
of  genotypes containing a low activity al-
lele in those who attempted a violent sui-
cide compared to those who attempted sui-
cide by a non-violent means. No evidence of  
an association with schizophrenia alone or 
with impulsivity was found compared with 
the control group [42]. Hung and associates 
found that male Chinese patients, carriers of  
the LA allele were significantly more likely to 
attempt suicide or attempt suicide by violent 
means compared to the control group. How-
ever, no association was found when exam-
ining the results through traditional biallelic 
5-HTTLPR methods [44]. It is interesting to 
mention a case of  a highly aggressive schizo-
phrenic patient of  Libyan Jewish origin who 
ultimately committed suicide. Molecular anal-
ysis demonstrated the long (L) and short (S) 
alleles of  the 5-HTTLPR polymorphism, 
however, the short allele was composed of  
13 repeating units, i.e. 23 base pairs shorter 
than the standard short allele. This unusual 
allele was not detected in any DNA sample 
of  a control group consisting of  172 healthy 
individuals and 361 patients with various psy-
chiatric illnesses, including 150 patients with 
schizophrenia [45].
Other serotonergic polymorphisms have 
been investigated rarely, mostly resulting in 
negative associations. In a study performed 
on 115 Chinese patients examined a role 
of  serotonin 2A receptor polymorphisms 
(HTR2A) in modulating emotional manage-
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ment in schizophrenia. Heterozygotes of  the 
A/G genotype were shown to have better 
emotional control than the G/G homozy-
gotes, but not and A/A ones. This suggests a 
role for HTR2A gene variation in emotional 
regulation, which, if  disrupted, could lead to 
aggressive behaviour [43]. Also, it is worth 
noting that no association was found be-
tween aggressive behaviour in schizophrenia 
and the A218C polymorphism of  tryptophan 
hydroxylase 1 gene [46], nor the serotonin 1B 
receptor (A161T) gene polymorphism [47].
Brain-derived neurotrophic factor (BDNF)
BDNF is a type of  nerve growth factors, 
which is highly expressed in the adult brain 
and plays a crucial role in the development, 
survival and functional maintenance of  neu-
rons. BDNF is an essential modulator of  syn-
aptic transmission and plasticity in the central 
nervous system and is involved in cognitive 
processes such as memory and learning. Ani-
mal model studies suggest that changes to the 
BDNF gene could be involved in aggressive 
behaviour [48,49].
In a study of  118 Italian patients, the as-
sociation of  the Val66Met BDNF gene poly-
morphism with the aggressive behaviour of  
schizophrenia patients was examined. Pa-
tients with the Met/Val genotype were sig-
nificantly more aggressive compared to those 
with the Val/Val genotype, as measured by 
the modified overt aggression scale (MOAS). 
Analysing the MOAS subscales authors 
found that overt physical aggression mainly 
contributed to this result. These findings are 
in contrast to studies conducted in Chinese 
and Korean patients where no association 
was found between Val66Met polymorphism 




MTHFR is an enzyme involved in the 
folate metabolism pathway which catalyses 
conversion of  methylenetetrahydrofolate to 
methyltetrahydrofolate, the primary circu-
lating form of  folate. Reduced MTHFR ac-
tivity is associated with impaired folate pro-
cessing leading to a decrease of  folate levels 
in blood. Circulating folate is a co-substrate 
for the remethylation of  homocysteine into 
methionine which is a precursor of  S-adeno-
sylmethionine (SAM), a major donor of  the 
methyl group. Variants of  the MTHFR gene 
and different levels of  circulating folate have 
important influence DNA methylation and 
gene regulation. Defects in remethylation and 
transsulfuration of  homocysteine to cysteine 
are associated with an elevated level of  to-
tal plasma homocysteine [52]. MTHFR gene 
polymorphisms rs1801131 and rs1801133 are 
associated with decreased enzymatic activity, 
leading to increased plasma homocysteine 
levels. Higher plasma homocysteine may lead 
to subcortical limbic hyperactivity, which af-
fects the occurrence of  aggressive behaviour.
To the best of  our knowledge a single 
study examined the association of  aggres-
sive behaviour in schizophrenia and MTHFR 
gene polymorphisms. Dong and associates 
have shown that the T-allele polymorphism 
rs1801133 and the T-C haplotype polymor-
phism rs1801131 are associated with ag-
gressive behaviour in Chinese patients with 
schizophrenia [53].
Neurogranin (NRGN)
NRGN gene is considered an important 
candidate gene for development of  schizo-
phrenia due to its function and location. 
Genome-wide linkage studies found an as-
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sociation of  chromosome 11q23.3-24 with 
schizophrenia, and NRGN is located on 
chromosome 11q24.2 which is consistent 
with this chromosomal region. NRGN en-
codes a substrate for postsynaptic protein ki-
nase C that binds to calmodulin (CaM) in the 
absence of  calcium. NRGN also regulates 
CaM release and activation of  CaM-Ca2+ 
dependent enzymes, mediating the N-meth-
yl-D-aspartate (NMDA) signalling pathway, 
which plays an important role in the learn-
ing and memory neuroplasticity. It is also in-
volved in the pathophysiology of  glutamate 
in schizophrenia.
So far, only one study has examined the 
association of  polymorphisms of  this gene 
with violence in schizophrenia. In 2015, 
Su and associates demonstrated that the 
CC genotype of  the rs12807809 polymor-
phism is associated with a higher score in the 
PANSS aggression and activation subscales 
than the other genotypes. Also, Han Chinese 
with schizophrenia, carriers of  the C allele of  
the rs12807809 polymorphism, had higher 
scores of  general, activation, depression, ag-
gression, and global symptoms than carriers 
of  the T allele [54].
Dopamine receptor 4 gene (DRD4)
Dopamine receptors are involved in a 
number of  neurological processes such as 
cognition, memory, learning, motor control, 
as well as in the modulation of  neuroendo-
crine signalling. They are also associated with 
numerous neurological and psychiatric disor-
ders. DRD4 is located close to the telomere 
of  the chromosome 11p. It has a variable 
number of  tandem repeats polymorphism of  
the 48 base pairs in the third exon. Repeti-
tions range from 2 to 11 times, with the most 
common variants being 2 (2R), 4 (4R) and 7 
(7R) repetitions. The frequency of  variants 
varies greatly between ethnic groups. These 
variations affect the function of  the recep-
tor itself, and the 7-repetition allele encodes 
a receptor with a lower affinity for dopamine 
[55]. In 2005, Fresan and associates demon-
strated the association of  this polymorphism 
with aggression in patients with schizophre-
nia. Also, the frequency of  carriers of  the 7R 
allele was higher in the aggressive group com-
pared to the control group. Analysis of  the 
OAS scale revealed that carriers of  DRD4-
7R alleles had a significantly higher score in 
physical aggression toward others than carri-
ers of  other alleles [39].
Tumor necrosis factor receptor 1 (TNFR1)
Tumor necrosis factor alpha (TNFα) is 
an important susceptibility gene for schizo-
phrenia as elevated TNFα levels have been 
demonstrated in patients with schizophre-
nia. It exerts its activity through TNFR1 and 
TNFR2, which are constitutively expressed 
on all types of  neural cells. TNFR1 plays an 
important role in inducing various cellular re-
sponses, such as cell death, differentiation or 
inflammation. In patients with schizophre-
nia, there is an increase in brain and serum 
TNFR1 levels over time, and an association 
between TNFR1 levels and the severity of  
schizophrenia symptoms has been demon-
strated.
A study of  388 Polish patients with para-
noid schizophrenia matched with 657 healthy 
controls demonstrated an association be-
tween intensity of  excitement symptoms 
measured by the PANSS scale and rs4149577 
and rs1860545 polymorphisms in male pa-
tients. This also resulted in increased risk of  
violent behaviour and non-adherence to psy-
chopharmacotherapy [56].
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Conclusion
Schizophrenia is a complex chronic disor-
der characterized by heterogeneous clinical 
features whose etiology is not fully under-
stood, though it is well known that various 
environmental and social factors may con-
tribute to the development of  the disease in 
predisposed individuals. Due to insufficient 
understanding of  the biological basis of  
schizophrenia, there are currently no bio-
chemical markers that would help us define a 
diagnosis of  schizophrenia, and it is still diag-
nosed based on classical descriptive criteria. 
Numerous studies have sought to determine 
the genetic basis of  the disorder, demonstrat-
ing the association of  numerous genes and 
their polymorphisms with the development 
of  schizophrenia and making it clear that it 
will not be possible to detect a unique genetic 
aberration for such a heterogeneous disease. 
Studies focusing on one or several symptom 
clusters of  schizophrenia faced the same 
problem, with ambiguous findings. Aggres-
sive symptoms in schizophrenia are no ex-
ception, even though numerous studies have 
established an association between schizo-
phrenia and violent behaviour, there are rela-
tively few of  them that have addressed the 
role of  genetics in the aggressive behaviour 
of  patients with schizophrenia. Since aggres-
sion is an extremely complex form of  be-
haviour which can be manifested in several 
different ways, there is no single established 
definition of  aggression, which makes it im-
possible to compare similar studies. Despite 
the complexity of  genetic research, environ-
mental and epigenetic factors which contrib-
ute to the development of  both schizophre-
nia itself  and complex behavioural patterns 
such as aggression are often not considered. 
All above stated limits the applicability of  ge-
netic testing in routine clinical practice. Un-
ambiguous definition of  aggression, environ-
mental factors, and epigenetic changes for 
the purpose of  genetic research on schizo-
phrenia could contribute to the development 
of  predictive models of  violent behaviour 
and, consequently, the prevention thereof.
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Genetski polimorfizmi serotoninskog i dopaminskog sustava u 
odnosu na nasilje i agresiju u shizofreniji
Sažetak - Shizofrenija je kronična bolest, rekurentnog tijeka, koja u konačnici dovodi do propadanja kogni-
tivnih i emocionalnih funkcija. Iako etiologija same bolesti nije u potpunosti poznata, najvjerojatnije je multi-
faktorijalna, uz podjednaku važnost okolišnih i genetskih čimbenika. Premda većina psihijatrijskih pacijenata 
nije nasilna, dobro je poznata povezanost između shizofrenije i agresivnog ponašanja. Također je poznato 
da brojni psihološki i socijalni čimbenici utječu na pojavu nasilja u pacijenata sa shizofrenijom, ali je nedo-
voljno istražen utjecaj genetskih promjena i polimorfizama gena na pojavu nasilja u ovoj skupini pacijenata. 
Nasilje i agresija su kompleksan obrazac ponašanja što dovodi do poteškoća u usporedivosti genetskih studija 
i kliničkoj primjenjivosti istih. U ovome radu su sistematizirano prikazana dostupna saznanja o potencijal-
noj povezanosti polimorfizama gena s implikacijama na serotonergičko i dopaminergičko funkcioniranje i 
agresivnih simptoma  te nasilnog ponašanja  u shizofreniji. 
Ključne riječi: dopamin, serotonin, genetski polimorfizam, agresija, nasilje
